Please note our website will be undergoing maintenance on Tuesday, May 28, 2024. e-Commerce transactions and new registrations will be temporarily unavailable during this time. We apologize for any inconvenience this may cause.
Open access

Management of infections in the immunocompromised child: General principles

Publication: LymphoSign Journal
12 August 2016

Abstract

Infections represent an ongoing challenge for immunocompromised patients. Children are particularly vulnerable because of several age-related issues that relate in part to immune prematurity. This review addresses the challenges in managing infections among immunocompromised children and highlights several general principles that guide management.
Statement of novelty: This work provides important guidance to clinicians who are involved in the management of pediatric patients with an ever-expanding spectrum of immunocompromising disorders.

Formats available

You can view the full content in the following formats:

REFERENCES

Adeli M.M. and Buckley R.H.2010. Why newborn screening for severe combined immunodeficiency is essential: A case report. Pediatrics. 126(2):e465–e469.
Allen U.D. and Green M.2010. Prevention and treatment of infectious complications after solid organ transplantation in children. Pediatr Clin North Am.57(2):459–479.
Allen U.D. and Preiksaitis J.K.AST Infectious Diseases Community of Practice. 2013. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant.13(Suppl 4):107–120.
American Academy of Pediatrics. 2015a. Pertussis (Pneumococcal Infections) in Kimberlin D.W., Brady M.T., Jackson M.A., and Long S.S., eds., Report of the Committee on Infectious Diseases, 30th ed., Elk Grove Village, IL: American Academy of Pediatrics, 626–638.
American Academy of Pediatrics. 2015b. Pertussis (Pneumocystis jirovecci Infections) in Kimberlin D.W., Brady M.T., Jackson M.A., and Long S.S., eds., Report of the Committee on Infectious Diseases, 30th ed., Elk Grove Village, IL: American Academy of Pediatrics, 638–644.
American Thoracic Society, Centers for Disease, Control and Prevention, and Infectious Diseases Society of America. 2005. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling tuberculosis in the United States. Am J Respir Crit Care Med.172(9):1169–1227.
ARDS Definition Task Force; Ranieri V.M.Rubenfeld G.D.Thompson B.T.Ferguson N.D.Caldwell E.Fan E.Camporota L.Slutsky A.S.2012. Acute respiratory distress syndrome: The Berlin Definition. JAMA.307(23):2526–2533.
Beisel W.R.1996. Nutrition in pediatric HIV infection: Setting the research agenda. Nutrition and immune function: Overview. J Nutr.126(10 Suppl):2611S-2615S.
Byrd R.P. 2015. Drug-Induced pulmonary toxicity. Available from http://emedicine.medscape.com/article/1343451-overview.
Cattaneo C., Quaresmini G., Casari S., Capucci M.A., Micheletti M., Borlenghi E., Signorini L., Re A., Carosi G., and Rossi G.2008. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: Results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother.61(3):721–728.
Chen C.Y., Tang J.L., Hsueh P.R., Yao M., Huang S.Y., Chen Y.C., Chen Y.C., Shen M.C., Wang C.H., Tsai W., Chang S.C., Tien H.F., and Luh K.T. 2004. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc.103(7):526–532.
Cordonnier C., Pautas C., Maury S., Vekhoff A., Farhat H., Suarez F., Dhedin N., Isnard F., Ades L., Kuhnowski F., Foulet F., Kuentz M., Maison P., Bretagne S., and Schwarzinger M.2009. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: A randomized, controlled trial. Clin Infect Dis.48(8):1042–1051.
Edgar J.D.2008. T cell immunodeficiency. J Clin Pathol.61(9):988–993.
El Kholy A.A., Mostafa N.A., Ali A.A., Soliman M.M., El-Sherbini S.A., Ismail R.I., El Basha N., Magdy R.I., El Rifai N., and Hamed D.H.2016. The use of multiplex PCR for the diagnosis of viral severe acute respiratory infection in children: A high rate of co-detection during the winter season. Eur J Clin Microbiol Infect Dis.
Englund J., Feuchtinger T., and Ljungman P.2011. Viral infections in immunocompromised patients. Biol Blood Marrow Transplant.17(1 Suppl):S2–S5.
Fernandez-Ruiz M., Kumar D., and Humar A.2014. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clin Transl Immunology.3(2):e12.
Ferrara J.L. and Deeg H.J.1991. Graft-versus-host disease. N Engl J Med.324(10):667–674.
Ferrer R., Martin-Loeches I., Phillips G., Osborn T.M., Townsend S., Dellinger R.P., Artigas A., Schorr C., and Levy M.M.2014. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program. Crit Care Med.42(8):1749–1755.
Forsyth K., Plotkin S., Tan T., and Wirsing von Konig C.H.2015. Strategies to decrease pertussis transmission to infants. Pediatrics.135(6):e1475–e1482.
Freifeld A.G., Bow E.J., Sepkowitz K.A., Boeckh M.J., Ito J.I., Mullen C.A., Raad II, Rolston K.V., Young J.A., and Wingard J.R., andInfectious Diseases Society of America. 2011. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis.52(4):e56–e93.
Fried A.J. and Bonilla F.A.2009. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev.22(3):396–414.
Gaieski D.F., Mikkelsen M.E., Band R.A., Pines J.M., Massone R., Furia F.F., Shofer F.S., and Goyal M.2010. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med.38(4):1045–1053.
Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., Auinger P., Griffin M.R., Poehling K.A., Erdman D., Grijalva C.G., Zhu Y., and Szilagyi P.2009. The burden of respiratory syncytial virus infection in young children. N Engl J Med.360(6):588–598.
Ison M.G. and Hayden F.G.2002. Viral infections in immunocompromised patients: What’s new with respiratory viruses?Curr Opin Infect Dis.15(4):355–367.
James S.H. and Kimberlin D.W.2015. Neonatal Herpes Simplex Virus Infection. Infect Dis Clin North Am.29(3):391–400.
Janeway C.A., Jr, Travers P., Walport M., and Schlomchik M.2001. Immunobiology: The Immune System in Health and Disease. 5th Edition., New York: Garland Science.
Jyonouchi S., McDonald-McGinn D.M., Bale S., Zackai E.H., and Sullivan K.E.2009. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: A comparison of immunologic and nonimmunologic phenotypic features. Pediatrics.123(5):e871–e877.
Katona P. and Katona-Apte J.2008. The interaction between nutrition and infection. Clin Infect Dis.46(10):1582–1588.
Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Danziger-Isakov L., and Humar A., andTransplantation Society International CMV Consensus Group2013. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation.96(4):333–360.
Kucharski A.J., Eggo R.M., Watson C.H., Camacho A., Funk S., and Edmunds W.J.2016. Effectiveness of ring vaccination as control strategy for Ebola virus disease, Emerg Infect Dis.22(1):105–108.
Kumar A., Roberts D., Wood K.E., Light B., Parrillo J.E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A., and Cheang M.2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med.34(6):1589–1596.
Lehners N., Tabatabai J., Prifert C., Wedde M., Puthenparambil J., Weissbrich B., Biere B., Schweiger B., Egerer G., and Schnitzler P.2016. Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders. PLoS One.11(2):e0148258.
Lejkowski M., Maheshwari A., Calhoun D.A., Christensen R.D., Skoda-Smith S., and Dabrow S.2003. Persistent perianal abscess in early infancy as a presentation of autoimmune neutropenia. J Perinatol.23(5):428–430.
Lin R.Y. and Kaliner M.A.2014. Hypogammglobulinemia. Available from http://emedicine.medscape.com/article/136471-overview.
Ljungman P., Griffiths P., and Paya C.2002. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis.34(8):1094–1097.
Lublin M., Bartlett D.L., Danforth D.N., Kauffman H., Gallin J.I., Malech H.L., Shawker T., Choyke P., Kleiner D.E., Schwartzentruber D.J., Chang R., DeCarlo E.S., and Holland S.M.2002. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg.235(3):383–391.
Malhotra B., Swamy M.A., Reddy P.V., Kumar N., and Tiwari J.K.2016. Evaluation of custom multiplex real-time RT-PCR in comparison to fast-track diagnostics respiratory 21 pathogens kit for detection of multiple respiratory viruses. Virol J.13:91.
Meissner H.C., Welliver R.C., Chartrand S.A., Law B.J., Weisman L.E., Dorkin H.L., and Rodriguez W.J.1999. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion. Pediatr Infect Dis J.18(3):223–231.
Merril W.W. 2016. Radiation-induced lung injury. UpToDate. Available from www.uptodate.com/contents/radiation-induced-lung-injury.
Montilla N.A., Blas M.P., López Santalla M., and Martín Villa J.M.2004. Mucosal Immune System: A brief review. Inmunología.23:207–216.
Napenas J.J., Brennan M.T., Bahrani-Mougeot F.K., Fox P.C., and Lockhart P.B.2007. Relationship between mucositis and changes in oral microflora during cancer chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.103(1):48–59.
Oliveira A.L., de Souza M., Carvalho-Dias V.M., Ruiz M.A., Silla L., Tanaka P.Y., Simoes B.P., Trabasso P., Seber A., Lotfi C.J., Zanichelli M.A., Araujo V.R., Godoy C., Maiolino A., Urakawa P., Cunha C.A., de Souza C.A., Pasquini R., and Nucci M.2007. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant.39(12):775–781.
Parkin J. and Cohen B.2001. An overview of the immune system. Lancet.357(9270):1777–1789.
Ram S., Lewis L.A., and Rice P.A.2010. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev.23(4):740–780.
Ramphal R.2004. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis.39(Suppl 1):S25–S31.
Renaud C. and Englund J.A.2012. Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients. Antivir Ther.17(1 Pt B):175–191.
Rijkers G.T., Sanders E.A., Breukels M.A., and Zegers B.J.1998. Infant B cell responses to polysaccharide determinants. Vaccine.16(14–15):1396–1400.
Saag M.S., Graybill R.J., Larsen R.A., Pappas P.G., Perfect J.R., Powderly W.G., Sobel J.D., and Dismukes W.E.2000. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis.30(4):710–718.
Shankar G. and Cohen D.A.2001. Idiopathic pneumonia syndrome after bone marrow transplantation: The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol.82(2):101–113.
Shankar S.M. and Nania J.J.2007. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy. Paediatr Drugs.9(5):301–309.
Silliman C.C., Ambruso D.R., and Boshkov L.K.2005. Transfusion-related acute lung injury. Blood.105(6):2266–2273.
Soler-Palacin P., Margareto C., Llobet P., Asensio O., Hernandez M., Caragol I., and Espanol T.2007. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr).35(3):83–89.
Sonis S.T., Peterson D.E., McGuire D.B., and Williams D.A.2001. Prevention of mucositis in cancer patients. J Natl Cancer Inst Monogr.29:1–2.
Spitzer T.R.2001. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant.27(9):893–898.
Stokman M.A., Spijkervet F.K., Burlage F.R., Dijkstra P.U., Manson W.L., de Vries E.G., and Roodenburg J.L.2003. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: A double-blind randomised clinical trial. Br J Cancer.88(7):1012–1016.
Subbarayan A., Colarusso G., Hughes S.M., Gennery A.R., Slatter M., Cant A.J., and Arkwright P.D.2011. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics.127(5):810–816.
Vera-Llonch M., Oster G., Hagiwara M., and Sonis S.2006. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 106(2):329–336.
Yin S., Powell E.C., and Trainor J.L.2011. Serious bacterial infections in febrile outpatient pediatric kidney transplant recipients. Pediatr Infect Dis J.30(2):136–140.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 3Number 3September 2016
Pages: 87 - 98

History

Received: 28 June 2016
Accepted: 10 August 2016
Accepted manuscript online: 12 August 2016

Authors

Affiliations

Upton D. Allen [email protected]
Professor of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media